Advertisement
AIZ or DVA or TECH
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AIZ’s FA Score shows that 1 FA rating(s) are green whileDVA’s FA Score has 3 green FA rating(s), and TECH’s FA Score reflects 2 green FA rating(s).
- AIZ’s FA Score: 1 green, 4 red.
- DVA’s FA Score: 3 green, 2 red.
- TECH’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AIZ’s TA Score shows that 4 TA indicator(s) are bullish while DVA’s TA Score has 3 bullish TA indicator(s), and TECH’s TA Score reflects 6 bullish TA indicator(s).
- AIZ’s TA Score: 4 bullish, 4 bearish.
- DVA’s TA Score: 3 bullish, 5 bearish.
- TECH’s TA Score: 6 bullish, 4 bearish.
Price Growth
AIZ (@Property/Casualty Insurance) experienced а +1.76% price change this week, while DVA (@Hospital/Nursing Management) price change was +8.59% , and TECH (@Biotechnology) price fluctuated +3.87% for the same time period.
The average weekly price growth across all stocks in the @Property/Casualty Insurance industry was +2.22%. For the same industry, the average monthly price growth was +3.02%, and the average quarterly price growth was -4.30%.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +4.46%. For the same industry, the average monthly price growth was +7.62%, and the average quarterly price growth was +23.54%.
The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.
Reported Earning Dates
AIZ is expected to report earnings on Aug 04, 2026.
DVA is expected to report earnings on Aug 05, 2026.
TECH is expected to report earnings on Aug 11, 2026.
Industries' Descriptions
@Property/Casualty Insurance (+2.22% weekly)Property and casualty companies insure against accidents of non-physical harm, such as lawsuits, damage to personal assets, car crashes and more. Progressive Corporation, Travelers Companies, Inc. and Allstate Corporation are some of the biggest providers of such products.
@Hospital/Nursing Management (+4.46% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
@Biotechnology (+0.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| AIZ | DVA | TECH | |
| Capitalization | 12.9B | 13.4B | 8.46B |
| EBITDA | N/A | 2.71B | 257M |
| Gain YTD | 9.176 | 83.663 | -7.885 |
| P/E Ratio | 13.38 | 20.10 | 77.14 |
| Revenue | 13.2B | 13.8B | 1.21B |
| Total Cash | N/A | 667M | 210M |
| Total Debt | 2.21B | 13.2B | 290M |
AIZ | DVA | TECH | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 75 | 27 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 52 Fair valued | 75 Overvalued | 2 Undervalued | |
PROFIT vs RISK RATING 1..100 | 35 | 44 | 100 | |
SMR RATING 1..100 | 58 | 5 | 85 | |
PRICE GROWTH RATING 1..100 | 20 | 6 | 47 | |
P/E GROWTH RATING 1..100 | 67 | 21 | 31 | |
SEASONALITY SCORE 1..100 | 85 | 50 | 36 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECH's Valuation (2) in the Biotechnology industry is somewhat better than the same rating for AIZ (52) in the Specialty Insurance industry, and is significantly better than the same rating for DVA (75) in the Medical Or Nursing Services industry. This means that TECH's stock grew somewhat faster than AIZ’s and significantly faster than DVA’s over the last 12 months.
AIZ's Profit vs Risk Rating (35) in the Specialty Insurance industry is in the same range as DVA (44) in the Medical Or Nursing Services industry, and is somewhat better than the same rating for TECH (100) in the Biotechnology industry. This means that AIZ's stock grew similarly to DVA’s and somewhat faster than TECH’s over the last 12 months.
DVA's SMR Rating (5) in the Medical Or Nursing Services industry is somewhat better than the same rating for AIZ (58) in the Specialty Insurance industry, and is significantly better than the same rating for TECH (85) in the Biotechnology industry. This means that DVA's stock grew somewhat faster than AIZ’s and significantly faster than TECH’s over the last 12 months.
DVA's Price Growth Rating (6) in the Medical Or Nursing Services industry is in the same range as AIZ (20) in the Specialty Insurance industry, and is somewhat better than the same rating for TECH (47) in the Biotechnology industry. This means that DVA's stock grew similarly to AIZ’s and somewhat faster than TECH’s over the last 12 months.
DVA's P/E Growth Rating (21) in the Medical Or Nursing Services industry is in the same range as TECH (31) in the Biotechnology industry, and is somewhat better than the same rating for AIZ (67) in the Specialty Insurance industry. This means that DVA's stock grew similarly to TECH’s and somewhat faster than AIZ’s over the last 12 months.
| AIZ | DVA | TECH | |
|---|---|---|---|
| RSI ODDS (%) | 3 days ago 36% | 3 days ago 55% | 3 days ago 71% |
| Stochastic ODDS (%) | 3 days ago 49% | 3 days ago 63% | 3 days ago 71% |
| Momentum ODDS (%) | 3 days ago 62% | 3 days ago 66% | 3 days ago 78% |
| MACD ODDS (%) | 3 days ago 55% | 3 days ago 64% | 3 days ago 64% |
| TrendWeek ODDS (%) | 3 days ago 56% | 3 days ago 65% | 3 days ago 66% |
| TrendMonth ODDS (%) | 3 days ago 56% | 3 days ago 62% | 3 days ago 62% |
| Advances ODDS (%) | 3 days ago 53% | 3 days ago 66% | 6 days ago 71% |
| Declines ODDS (%) | 6 days ago 45% | 7 days ago 56% | 13 days ago 74% |
| BollingerBands ODDS (%) | 3 days ago 41% | 3 days ago 57% | 3 days ago 66% |
| Aroon ODDS (%) | 3 days ago 51% | 3 days ago 58% | 3 days ago 76% |
Advertisement
AIZ and
Correlation & Price change
A.I.dvisor indicates that over the last year, AIZ has been closely correlated with AXS. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if AIZ jumps, then AXS could also see price increases.
DVA and
Correlation & Price change
A.I.dvisor indicates that over the last year, DVA has been loosely correlated with UHS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DVA jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To DVA | 1D Price Change % | ||
|---|---|---|---|---|
| DVA | 100% | +2.37% | ||
| UHS - DVA | 42% Loosely correlated | +0.25% | ||
| FMS - DVA | 35% Loosely correlated | +2.91% | ||
| CON - DVA | 29% Poorly correlated | +3.27% | ||
| ACHC - DVA | 28% Poorly correlated | -1.17% | ||
| JYNT - DVA | 25% Poorly correlated | +5.27% | ||
More | ||||